Juvenile Idiopathic Arthritis: Filgotinib Study

We are studying how the medication filgotinib works in children and teens with juvenile idiopathic arthritis. The trial will also evaluate its safety and how well young patients accept the medication.

≤3 months ≤5 visits Safety phase (I)Post-Trial Drug Access No Placebo Investigational Medicines OralPediatricsRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Jyseleca

Jyseleca is a medicine used to treat moderate-to-severe rheumatoid arthritis and ulcerative colitis.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Filgotinib

Filgotinib is a substance that reduces inflammation and helps treat rheumatoid arthritis and other inflammatory joint conditions.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Glpg0634

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Centre Hospitalier Universitaire Amiens Picardie

Hepatology Gastroenterology Nutrition-Endocrinology-Nephrology-Rheumatology

Colomiers, France

Bicetre Hospital

Pediatric Rheumatology

Croulebarbe, France

Charite Universitaetsmedizin Berlin KöR

Klinik for Padiatrie mit Schwerpunkt Pneumologie

Berlin, Germany

Sponsor: Alfasigma S.p.A.

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.